Thanks to ambitious policies and the New Industrial Master Plan 2030 (NIMP 2030), Malaysia is positioning itself as a future global hub for medical technology (medtech). By combining innovation, strategic partnerships, and the adoption of Industry 4.0 technologies, the country is committed to transforming the healthcare sector while boosting its economy.
Key Points of This Transformation
- A rapidly growing sector: More than 200 medical device manufacturers generated USD 6.37 billion in exports in 2023, including 30 multinational companies such as Abbott and B. Braun.
- Visionary policies: NIMP 2030 promotes the integration of AI, IoT, and robotics to enhance the efficiency and sustainability of the industry.
- A global contribution: The medical device market is expected to grow from USD 542 billion in 2024 to nearly USD 887 billion by 2032.
With a 30% increase in exports in 2023 and initiatives to integrate into global supply chains, Malaysia is ready to tackle tomorrow’s healthcare challenges while becoming a key player in ASEAN and the global medtech sector.
